This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cipla Vs Sun Pharmaceutical : Pharma companies bear enormous responsibility for producing medicines and monetizing the time and effort spent on research and development for years by using patent protection. In this article, we will compare Cipla Vs Sun Pharmaceutical, both of which are involved in the pharmaceutical industry.
We all know that the pharmaceutical industry is a complex ecosystem where countless components converge to produce life – saving medicines. India is a powerhouse within this global pharmaceutical landscape. Here’s where Sigachi industries play a major role through their production of Microcrystalline Cellulose (MCC).
After this, we’ll quickly move through the financials of the stock. A highlight of the future plans of the company and a summary conclude the article at the end. Additionally, it also develops prebiotics and formulations among other products for the pharmaceutical industry. Financial Year Debt / Equity Interest Coverage 2023 0.32
Next, we’ll go through their financials. Lastly, a highlight of their future plans and a summary conclude the article. FY 2022-23 Annual Report Its chemicals find their end applications in a multitude of industries including petrochemicals, rubber, agrochemicals, paper, pharmaceuticals, detergents, and more.
Fundamental Analysis Of Zydus Lifesciences: Following the pandemic outbreak, global health issues have gained attention, resulting in a greater focus on pharmaceutical corporations. Zydus Lifesciences is one of these Indian pharmaceutical businesses. Following that, we’ll go into the stock’s financials. 2022 nil 26.3
Next, we’ll look at the market size and opportunities. After this, we’ll race through the financials of the stock. A highlight of the future plans and a summary conclude the article at the end. Furthermore, it also has domestic leadership in Diketene derivatives with a 55% market share.
Some notable pharmaceutical companies have made their way to the Nifty Index and we’re going to perform a fundamental analysis of Divis Laboratories. Overview: Indian Pharmaceutical Industry When you consume medicine for certain ailments and diseases, you’re recommended by your doctor to consume it for its curing effect.
Fundamental Analysis Of Aarti Industries : Specialty chemicals have become essential in various industries ranging from pharmaceuticals, electronics, agriculture, and automotive. Following that, we’ll go into the stock’s financials. The article concludes with a highlight of future plans and a summary.
Fundamental Analysis Of Neuland Laboratories: Following the pandemic outbreak, worldwide health issues have become more prominent, leading to an increased focus on pharmaceutical companies. Following that, we’ll go into the stock’s financials. The article concludes with a highlight of future plans and a summary.
It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. According to the Economic Survey 2023, India’s domestic pharmaceuticalmarket was estimated at $41 billion. The roots of India’s pharmaceutical capabilities lay deep within its rich history. Kallam Anji Reddy.
We will take a look at the overview, financials, and future plans of CE Info Systems. Financial Year D/E Interest Coverage 2022-23 0.03 Market Cap (Cr.) The post Fundamental Analysis Of CE Info Systems (Map My India) – Future Plans & More appeared first on Trade Brains. 2020-21 0 32.21 2019-20 0 12.14
The Department of Pharmaceuticals, Ministry of Chemicals & Fertilisers, Government of India has recognised the company as the “Medical Devices Company of the Year 2018” and has been recognised as the Largest Exporter of Medical Devices from India for six years in a row. .) ₹ 13,969 EPS (TTM) ₹ 24.35 Stock P/E (TTM) 60.41
Pharmaceutical companies in India have come a long way in supplying medicines, and with more research, they are improving their products. In this article, we will look at the Fundamental Analysis of Lupin Limited, a company in the pharmaceutical industry. The Indian pharmaceuticalmarket is expected to reach US$130 billion by 2030.
A proper frequency plan will improve the sector’s efficiency and address issues. Disclaimer: The financials compared are the data of amalgamated companies from FY19 to FY23. .) ₹ 5,173.81 The post Fundamental Analysis Of Gateway Distriparks – Future Plans & More appeared first on Trade Brains. Stock P/E 17.72
It caters to multiple industries such as Automotive, Pharmaceuticals, Agrochemicals, Mining, Air Conditioning, and much more. Today, it is a leading Manufacturer of Specialty chemicals and pharmaceutical products. Pharmaceutical segments bring another 18% to the Company. 24,568 EPS ₹91.66 Stock P/E 11.7 Price to Book Value 1.3
We can dissect the business into two major verticals: Sugar and Engineering Sugar Processed Sugar: Triveni manufactures multi-grade sugar, White crystal Sugar, Raw Sugar, and pharmaceutical-grade Sugar. The Company is currently planning CAPEX to expand capacity to 1,100 KL per day. Market Cap (Cr.) 8,040.12 ₹8,758.72
Subsequently, let us see the industry overview and then dig deeper into the financial performance of the company. Later, we shall proceed with the future plans of the company. Future Plans Of Triveni Turbine Up to this point, we have understood the financial performance of the company. Promoters Holding (in %) 55.8%
It keeps allocating its resources primarily to branding, marketing, and sales supervision. As per the plan, TCPL Beverages & Foods, a wholly-owned subsidiary of TCPL, will merge with Tata Coffee’s plantation business. merged on January 1, 2024. So, one could say that the acquisition of NourishCo is yielding results.
Following that, we’ll go into the stock’s financials. The article concludes with a highlight of future plans and a summary. Pharmaceutical Industry : The use of compressed air in the pharmaceutical industry range is categorised into process air application and Direct contact application. billion to $24.6
The products offered by the company are being used in various industries such as food, beverages and pharmaceuticals. The company has a strong presence in the Indian market and exports its product to several countries around the world, which includes Europe, United States and Asia.
Their product categories cover a wide spectrum, catering to diverse business needs from FMCG, groceries to industrial machinery, engineering products, pharmaceuticals, electronics, automobile, chemicals and construction materials. 7% in Spares and supplies, Industrial & Engineering products. 6% in Apparel, clothing and garments.
In your quest for financial wellness, you have probably heard countless times the importance of investing as part of a well-rounded financialplan. While this is true, most articles don’t tell you how to invest wisely, what role investments play in your wealth-building journey or even what the Market can tell you. .
With subsidiaries in Nigeria and Ghana, their business is diverse and includes the sale of goods in ROPP (Roll on Pilfer Proof) caps for wines, pharmaceuticals, and beverages, galvanized sheets, metal color-coated sheets and coils, aluminum coils, and packaging paper for corrugated boxes. The company’s revenue increased by 11% to Rs.
The management plans to launch its EVs in the Indian market by 2025. It also exports its vehicles to more than 100 nations worldwide. As part of its EV efforts, the automobile giant has announced a big capital expenditure of Rs 10,400 crore for EVs and batteries manufacturing.
CMP (In Rs) 618 Market Cap (in Rs Crs) 382,314 Stock P/E 10.82 Debt Equity Ratio 0 Face value (in Rs) 10 Best Low PE Large Cap Stocks #2 – Dr. Reddy’s Laboratories Dr. Reddy’s Laboratories is an Indian Pharmaceutical company that was incorporated in 1984 by Anji Reddy in Hyderabad, India. Sector P/E 17.36 EPS (In Rs) 57.55
Its chemical intermediaries find use in products such as pharmaceuticals, agrochemicals, personal care, adhesives, paper, coatings, detergents, and more. Gland Pharma Pharmaceuticals 2,169 35,700. Dr Lal Pathlabs Pharmaceuticals ?2,381 Based out of Gujarat, the company produces organic, inorganic, fine, and specialty chemicals.
GGL has plans to increase its capital expenditure every year from now. Furthermore, the management notified in January this year that it has planned a CAPEX of Rs 900 crore over the next 12 to 18 months. It plans to monetize 5 more products and has a few more in the pipeline. Pharmaceuticals & Drugs ₹29,150.57 ₹242.80
In addition to this, the company has capacity expansion plans in place to double its epoxy capacity by FY24. Bajaj Finserv Financial Services 1,806 287,500. Torrent PharmaceuticalsPharmaceuticals 1,505 51,000. 1,000 crores. It sold its fertilizer business on a slum sale basis. HDFC Bank Banking 1,531 852,000.
They are the folks who understand and effectively use financial skills to manage their money. Yeah, that lot that talks about terms like compounding, risk profile, returns, retirement planning, budgeting, Investing, and whatnot! The one thing that these people are sure to talk about is the stock market. What is SIP?
The Institute exists to preserve, protect and defend fiduciary principles in investment advice, wealth management and financialplanning. From this vantagepoint, she gained unique insight into how financial advice and products are delivered to investors. Lee holds a Ph.D.
But as often is the case, the boom turned into a financialmarket bubble and the price/earnings ratio of the NRI 350 Index (a broad index of non-financial stocks) at the end of 1989 was over 50x, compared to the S&P 500® Industrial Index at 15x. financialmarkets, to be a global leader for more than a century.
But as often is the case, the boom turned into a financialmarket bubble and the price/earnings ratio of the NRI 350 Index (a broad index of non-financial stocks) at the end of 1989 was over 50x, compared to the S&P 500® Industrial Index at 15x. financialmarkets, to be a global leader for more than a century.
After that, we’ll go through the financials of the pharma stock. A highlight of the future plans and a summary conclude the article at the end. Company Overview Sun Pharmaceutical Industries Ltd. Industry Overview The global pharmaceutical is projected to grow at a CAGR of 3-6% to reach $1.8 trillion in value by 2026.
Fundamental Analysis of Glenmark Life Sciences: For some time now, Glenmark Life Sciences, a listed subsidiary of Glenmark Pharmaceuticals has been in the news. A highlight of the R&D spending, future plans and a summary conclude the article at the end. GPL) set up its active pharmaceutical ingredient (API) business.
India is emerging as a major player in the pharmaceutical industry, particularly in the development of cancer drugs. The rising number of cancer cases, both domestic and international, creates immense opportunities for pharmaceutical companies specializing in oncology treatments. Current Market Price ₹ 1,866.7
The company is into R&D which involves process chemistry, product development, active pharmaceutical ingredients (APIs), manufacture of complex formulations, and over-the-counter products. Cipla Cipla manufactures and distributes branded medicines, active pharmaceutical ingredients (APIs), and generics.
We’ll discuss these questions: The CFP Board has specifically stated that it wants the CFP® mark to be a requirement for anyone who practices financialplanning. The debaters are: Robert Wright, CFP®, a financial consultant with Advocacy Wealth Management. What is your opinion? Robert will be on the “for” team.
Food additives, animal feed, pharmaceuticals, dyes, textiles, and air pollution control are a few industries that make use of sodium bicarbonate. It has made significant expansion plans over the years. Tata Chemicals is the world’s third-largest producer of Soda Ash with a production capacity of 3670 KT. lakh tonnes. Tata Chemicals.
What’s more, pharmaceutical companies have created very effective therapeutics, including Paxlovid, a game-changing antiviral pill manufactured by Pfizer. History tells us this will never happen, but the mere game of political brinksmanship could rattle markets in the short-run. All these risks and fears are nothing new.
We organize all of the trending information in your field so you don't have to. Join 36,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content